Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-182-1 | CAS number: 21056-98-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 January 2016 to 22 June 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 2015
- Deviations:
- yes
- Remarks:
- Tp° in the incubator > 0.2°C.The SD value of viability (%) was 37.4% instead of 18% max for negative control tissues but homogenous results were obtained in test item treated tissues and historical data. No impact on the conclusion of the study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Deviations:
- yes
- Remarks:
- see above
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Calcium hydrogen phosphonate
- EC Number:
- 244-182-1
- EC Name:
- Calcium hydrogen phosphonate
- Cas Number:
- 21056-98-4
- Molecular formula:
- Ca.H3O3P
- IUPAC Name:
- calcium phosphonate
- Test material form:
- solid: crystalline
- Details on test material:
- Purity : 95%
Batch number: PCAF151028 Rns
CAS number : 21056-98-4
Chemical name : Phosphonic acid, calcium salt (1:1), Calcium hydrogen phosphonate
Manufacturing date : 28/10/2015
Shelf life or Expiry date : 28/10/2018
Date of analysis : 27/11/2015
Constituent 1
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- other: reconstructed human epidermis
- Details on test system:
- The 0.50 cm2 reconstructed epidermis (Episkin SA, RHE/S17 Batch No. 16-RHE-008)
Medium and Incubation T°C: 37°C - Control samples:
- yes, concurrent no treatment
- yes, concurrent positive control
- Amount/concentration applied:
- Amount applied per tissue : 16 mg
- Duration of treatment / exposure:
- Exposure period of 42 minutes, followed by rinsing. The rinsed tissues were checked for any coloration. There were incubated for a 41 hours and 05 minutes post-treatment incubation-period in fresh medium at 37°C, 5% CO2. Then the epidermis were put in contact with MTT solution. Observation of MTT-> formazan transformation by viable cells.
- Number of replicates:
- triplicates
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 100
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Remarks:
- the exact % viability value was 118 considered 100
- Other effects / acceptance of results:
- In the preliminary tests, the test item was found not to have direct MTT reducing properties or significant colouring potential.
Main test: All acceptance criteria for the negative and positive controls were fulfilled except that the standard deviation value of viability percent of the tissues treated with the negative control was 37.4% instead of 18% (maximal value) as initially scheduled in the study plan. Considering the study results obtained in the tissues treated with the test item and the historical data, this deviation is considered as without impact on the conclusion of the study. Indeed, the results of the tissues treated with the test item are homogenous and all markedly above the cut-off of 50%. The study was therefore considered to be valid.
Following a 42 minutes exposure and 42 hours of recovery period, the relative mean viability of the tissues treated with the test item was 118% (considered 100%) with a standard deviation of 13%.
As the mean viability was > 50% after the MTT reduction, the IL-1 a concentrations in culture media samples retained were analyzed by ELISA
The mean IL-1a concentration for treated tissues was 7.08 pg/mL vs 169.54 pg/mL in the positive control. Due to this value being below 60 pg/mL, the results met the criteria for an in vitro classification as non-irritant to skin.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In vitro, the test item is considered to be non-irritant to the skin.
- Executive summary:
The objective of this study was to evaluate the skin irritation potential of calcium hydrogen phosphonate using the Episkin reconstructed human epidermis model. The study design was based upon international guidelines (OECD Guideline No. 439 and Commission Regulation (EC) No. 761/2009, B.46).
Preliminary tests were performed to detect the ability of the test item to directly reduce MTT as well as its colouring potential. Following the preliminary tests, the skin irritation potential of the test item was tested in the main test. The test item and both the negative and positive controls were applied topically on triplicate tissues and incubated at room temperature for 42 minutes. At the end of the treatment period, each tissue was rinsed and incubated for 42 hours at 37.5°C, 5% CO2 in a humidified incubator. The cell viability was then assessed by means of the colourimetric MTT reduction assay.
Relative viability values were calculated for each tissue and expressed as a percentage of the mean viability of the negative control tissues which was set at 100% (reference viability).
In addition, the concentration of the inflammatory mediator IL-1awas evaluated in the culture medium retained following the 42-hour recovery period. This quantification, based on an ELISA assay, was performed since the mean relative viability of the test item-treated tissues was > 50% following the MTT reduction assay.
In the preliminary tests, the test item was found not to have direct MTT reducing properties or colouring potential.
In the main test, all acceptance criteria for the negative and positive controls were fulfilled except that the standard deviation value of viability percent of the tissues treated with the negative control was 37.4% instead of 18% (maximal value) as initially scheduled in the study plan. Considering the study results obtained in the tissues treated with the test item and the historical data, this deviation is considered as without impact on the conclusion of the study. Indeed, the results of the tissues treated with the test item are homogenous and all markedly above the cut-off of 50%. The study was therefore considered to be valid.
Following a 42 minutes exposure and 42 hours of recovery period, the relative mean viability of the tissues treated with the test item was 118% (considered 100%) with a standard deviation of 13%.
As the mean viability was > 50% after the MTT reduction, the IL-1aconcentrations in culture media samples retained were analyzed by ELISA
The mean IL-1aconcentration for treated tissues was 7.08 pg/mL vs 169.54 pg/mL in the positive control. Due to this value being below 60 pg/mL, the results met the criteria for an in vitro classification as non-irritant to skin.
Under the experimental conditions of this study, the test item is considered to be non-irritant to skin.
According to the results of this study, the classification of the test item should be:
. not classified (Directive 67/548/EEC) and no category (Regulation (EC) No. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.